This is a StreetInsider.com Premium Only Page

Arbutus Biopharma (ABUS) – Momentum Movers

Dec 1, 2021 11:59 AM Arbutus Biopharma (ABUS) Announces Preliminary Data Shows that Arbutus’ Capsid Inhibitor, AB-836 is Generally Safe and Well-Tolerated and Provides Robust Antiviral Activity

Dec 1, 2021 11:49 AM Arbutus Biopharma (ABUS) Pushes to Session Highs Following Patent Decision

Dec 1, 2021 09:26 AM

Jul 24, 2020 08:48 AM

Jul 23, 2020 02:29 PM

Jul 21, 2020 11:06 AM

Jul 20, 2020 01:52 PM

Sep 20, 2017 10:19 AM

Sep 20, 2017 10:12 AM